FDA Inspection 1014323 — The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services
The FDA completed an inspection of The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services on March 1, 2017 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Philadelphia, PA (United States)